Xiaomei Zhang, Gary J Jenkins, Kelly E Desino, Jinrong Liu, Mary Larsen, David M Stresser
{"title":"A Simplified Method for Determining Blood-to-Plasma Ratios <i>in vitro</i> and <i>ex vivo</i> by Matrix Matching with Blank Blood or Plasma.","authors":"Xiaomei Zhang, Gary J Jenkins, Kelly E Desino, Jinrong Liu, Mary Larsen, David M Stresser","doi":"10.2174/2949681016666230817150551","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This work describes a simplified, 96-well plate method for determining the blood-to-plasma concentration ratio (BP ratio) for small molecules.</p><p><strong>Methods: </strong>The need for calibration curves was eliminated using a matrix-matching approach in which blood samples were mixed with blank plasma and plasma samples were mixed with blank blood. As a result, both blood- and plasma-origin samples shared an equivalent matrix ahead of bioanalysis. In the <i>in vitro</i> assay, identical sample matrices were achieved by using the same source of blank plasma and blood.</p><p><strong>Results: </strong>In humans, a good correlation (R2 = 0.84) was observed between the data obtained in this matrix-matching method and literature values for 11 commercial compounds possessing a wide range of logD values across multiple chemical classes. In addition, this method showed good agreement with <i>in vitro</i> BP ratios for 10 proprietary compounds determined radiometrically (R2 = 0.72) in human and preclinical species. Finally, the <i>in vitro</i> matrix matching method compared favorably to BP ratios determined <i>ex vivo</i> for 13 proprietary and literature compounds (R2 = 0.87) in rat.</p><p><strong>Conclusion: </strong>This method, suitable for <i>in vitro</i> and <i>ex vivo</i> BP ratio determinations, is operationally efficient, robust, and a useful improvement upon previously published methods.</p>","PeriodicalId":72844,"journal":{"name":"Drug metabolism and bioanalysis letters","volume":" ","pages":"113-120"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug metabolism and bioanalysis letters","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/2949681016666230817150551","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: This work describes a simplified, 96-well plate method for determining the blood-to-plasma concentration ratio (BP ratio) for small molecules.
Methods: The need for calibration curves was eliminated using a matrix-matching approach in which blood samples were mixed with blank plasma and plasma samples were mixed with blank blood. As a result, both blood- and plasma-origin samples shared an equivalent matrix ahead of bioanalysis. In the in vitro assay, identical sample matrices were achieved by using the same source of blank plasma and blood.
Results: In humans, a good correlation (R2 = 0.84) was observed between the data obtained in this matrix-matching method and literature values for 11 commercial compounds possessing a wide range of logD values across multiple chemical classes. In addition, this method showed good agreement with in vitro BP ratios for 10 proprietary compounds determined radiometrically (R2 = 0.72) in human and preclinical species. Finally, the in vitro matrix matching method compared favorably to BP ratios determined ex vivo for 13 proprietary and literature compounds (R2 = 0.87) in rat.
Conclusion: This method, suitable for in vitro and ex vivo BP ratio determinations, is operationally efficient, robust, and a useful improvement upon previously published methods.